A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
Aaron J. Schmitz(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Ishmael D. Aziati(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Wafaa B. Alsoussi(Washington University in St. Louis), Adrianus C. M. Boon, Tingting Lei(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Zhuoming Liu(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Traci L. Bricker(Washington University in St. Louis), Rita E. Chen(Washington University in St. Louis), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Goran Bajic(Icahn School of Medicine at Mount Sinai), Jackson S. Turner(Washington University in St. Louis), Mahima Thapa(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Florian Krammer(Semmelweis University), Astha Joshi(Washington University in St. Louis), Tamarand L. Darling(Washington University in St. Louis), Sean P. J. Whelan(University of Pittsburgh Medical Center), Daniel C. Adelsberg(Icahn School of Medicine at Mount Sinai)
Cited by 21
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|Nature Immunology|2020|997